These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 35265530)

  • 1. Prevalence of
    Luo Y; Zhang S; Shang H; Cui W; Wang Q; Zhu B
    Front Cell Infect Microbiol; 2022; 12():801475. PubMed ID: 35265530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies.
    Zacharioudakis IM; Ziakas PD; Mylonakis E
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1650-4. PubMed ID: 24914822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
    Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
    Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.
    Alonso CD; Treadway SB; Hanna DB; Huff CA; Neofytos D; Carroll KC; Marr KA
    Clin Infect Dis; 2012 Apr; 54(8):1053-63. PubMed ID: 22412059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.
    Kamboj M; Xiao K; Kaltsas A; Huang YT; Sun J; Chung D; Wu S; Sheahan A; Sepkowitz K; Jakubowski AA; Papanicolaou G
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1626-33. PubMed ID: 24973628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.
    Morrisette T; Van Matre AG; Miller MA; Mueller SW; Bajrovic V; Abidi MZ; Benamu E; Kaiser JN; Barber GR; Chase S; Tobin J; Fish DN; Gutman JA
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2091-2097. PubMed ID: 31255741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.
    Kinnebrew MA; Lee YJ; Jenq RR; Lipuma L; Littmann ER; Gobourne A; No D; van den Brink M; Pamer EG; Taur Y
    PLoS One; 2014; 9(3):e90158. PubMed ID: 24662889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
    Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.
    Willems L; Porcher R; Lafaurie M; Casin I; Robin M; Xhaard A; Andreoli AL; Rodriguez-Otero P; Dhedin N; Socié G; Ribaud P; Peffault de Latour R
    Biol Blood Marrow Transplant; 2012 Aug; 18(8):1295-301. PubMed ID: 22387347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single-center study in Québec, Canada.
    Lavallée C; Labbé AC; Talbot JD; Alonso CD; Marr KA; Cohen S; Laverdière M; Dufresne SF
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Algorithm Addressing the Problem of Overdiagnosis of Clostridioides difficile Infections in Hematopoietic Stem Cell Transplantation Recipients: Effects on C. difficile Infection Rates and Patient Outcomes.
    Ford CD; Hoda D; Lopansri BK; Parra M; Sharma P; Asch J
    Transplant Cell Ther; 2023 Jul; 29(7):471.e1-471.e7. PubMed ID: 37086852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors and epidemiology of Clostridium difficile infection in hematopoietic stem cell transplant recipients during the peritransplant period.
    Aldrete SD; Kraft CS; Magee MJ; Chan A; Hutcherson D; Langston AA; Greenwell BI; Burd EM; Friedman-Moraco R
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27943501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation.
    Weber S; Scheich S; Magh A; Wolf S; Enßle JC; Brunnberg U; Reinheimer C; Wichelhaus TA; Kempf VAJ; Kessel J; Vehreschild MJGT; Serve H; Bug G; Steffen B; Hogardt M
    Int J Infect Dis; 2020 Oct; 99():428-436. PubMed ID: 32798661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
    Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
    Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation.
    Salamonowicz M; Ociepa T; Frączkiewicz J; Szmydki-Baran A; Matysiak M; Czyżewski K; Wysocki M; Gałązka P; Zalas-Więcek P; Irga-Jaworska N; Drożyńska E; Zając-Spychała O; Wachowiak J; Gryniewicz-Kwiatkowska O; Czajńska-Deptuła A; Dembowska-Bagińska B; Chełmecka-Wiktorczyk L; Balwierz W; Bartnik M; Zielezińska K; Urasiński T; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Pierlejewski F; Młynarski W; Gamrot-Pyka Z; Woszczyk M; Małas Z; Badowska W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Zaucha-Prażmo A; Kowalczyk J; Goździk J; Gorczyńska E; Jermakow K; Król A; Chybicka A; Ussowicz M; Kałwak K; Styczyński J
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1805-1812. PubMed ID: 29978303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Clostridium difficile infection among solid organ transplant recipients: a meta-analysis of published studies.
    Paudel S; Zacharioudakis IM; Zervou FN; Ziakas PD; Mylonakis E
    PLoS One; 2015; 10(4):e0124483. PubMed ID: 25886133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients.
    Barbar R; Hayden R; Sun Y; Tang L; Hakim H
    Pediatr Infect Dis J; 2021 Jul; 40(7):655-662. PubMed ID: 34097657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
    Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
    Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Huang AM; Marini BL; Frame D; Aronoff DM; Nagel JL
    Transpl Infect Dis; 2014 Oct; 16(5):744-50. PubMed ID: 25040545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.
    Chopra T; Chandrasekar P; Salimnia H; Heilbrun LK; Smith D; Alangaden GJ
    Clin Transplant; 2011; 25(1):E82-7. PubMed ID: 20973823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.